Cargando…

Translation and validation of the multiple sclerosis walking scale 12 for the German population – the MSWS-12/D

BACKGROUND: Gait impairment is a relevant problem in persons with multiple sclerosis (pwMS). The Multiple Sclerosis Walking Scale 12 (MSWS-12) is a valid Patient Reported Outcome Measure (PROM) to evaluate walking ability in pwMS. The aim of this study was to provide a linguistically valid translati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chorschew, Anna, Kesgin, Firat, Bellmann-Strobl, Judith, Flachenecker, Peter, Schiffmann, Insa, Rosenthal, Friederike, Althoff, Patrick, Drebinger, Daniel, Arsenova, Radina, Rasche, Ludwig, Dorsch, Eva-Maria, Heesen, Christoph, Paul, Friedemann, Stellmann, Jan-Patrick, Schmitz-Hübsch, Tanja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563229/ https://www.ncbi.nlm.nih.gov/pubmed/37814258 http://dx.doi.org/10.1186/s12955-023-02190-2

Ejemplares similares

Proposal for Post Hoc Quality Control in Instrumented Motion Analysis Using Markerless Motion Capture: Development and Usability Study
por: Röhling, Hanna Marie, et al.
Publicado: (2022)

Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study
por: Drebinger, Daniel, et al.
Publicado: (2020)

Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results
por: Mehta, Lahar, et al.
Publicado: (2015)

Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients
por: Limone, Brendan L, et al.
Publicado: (2013)

MRI Markers and Functional Performance in Patients With CIS and MS: A Cross-Sectional Study
por: Rasche, Ludwig, et al.
Publicado: (2018)

Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS—understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
por: Schiffmann, Insa, et al.
Publicado: (2020)

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort
por: Sidovar, Matthew F, et al.
Publicado: (2016)

Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2020)

Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2021)

aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis
por: Häußler, Vivien, et al.
Publicado: (2021)

Validating Predictors of Disease Progression in a Large Cohort of Primary-Progressive Multiple Sclerosis Based on a Systematic Literature Review
por: Stellmann, Jan-Patrick, et al.
Publicado: (2014)

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life
por: Krüger, Theresa, et al.
Publicado: (2017)

Progression events defined by home-based assessment of motor function in multiple sclerosis: protocol of a prospective study
por: Dorsch, Eva-Maria, et al.
Publicado: (2023)

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019)

Arm Ergometry to Improve Mobility in Progressive Multiple Sclerosis (AMBOS)—Results of a Pilot Randomized Controlled Trial
por: Heinrich, Inga, et al.
Publicado: (2021)

Smartphone Accelerometry: A Smart and Reliable Measurement of Real-Life Physical Activity in Multiple Sclerosis and Healthy Individuals
por: Zhai, Yuyang, et al.
Publicado: (2020)

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing
por: Grobelny, Anuschka, et al.
Publicado: (2017)

Altered Coupling of Psychological Relaxation and Regional Volume of Brain Reward Areas in Multiple Sclerosis
por: Wakonig, Katharina, et al.
Publicado: (2020)

Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy
por: Giovannetti, Ambra Mara, et al.
Publicado: (2020)

Understanding Magnetic Resonance Imaging in Multiple Sclerosis (UMIMS): Development and Piloting of an Online Education Program About Magnetic Resonance Imaging for People With Multiple Sclerosis
por: Freund, Magalie, et al.
Publicado: (2022)

Impairment and restrictions in possibly benign multiple sclerosis
por: Schaefer, Laura Melanie, et al.
Publicado: (2019)

Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
por: Stellmann, Jan-Patrick, et al.
Publicado: (2015)

T1 Relaxation Times in the Cortex and Thalamus Are Associated With Working Memory and Information Processing Speed in Patients With Multiple Sclerosis
por: Thaler, Christian, et al.
Publicado: (2021)

Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders
por: Gigengack, Norman K., et al.
Publicado: (2022)

Similar neural pathways link psychological stress and brain-age in health and multiple sclerosis
por: Schulz, Marc-Andre, et al.
Publicado: (2023)

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
por: Blindenbacher, Nelly, et al.
Publicado: (2020)

Placebo Cohorts in Phase-3 MS Treatment Trials – Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data
por: Stellmann, Jan-Patrick, et al.
Publicado: (2012)

T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis
por: Thaler, Christian, et al.
Publicado: (2017)

Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients
por: Stellmann, JP, et al.
Publicado: (2015)

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD
por: Schroeder-Castagno, Maria, et al.
Publicado: (2022)

RGB-Depth Camera-Based Assessment of Motor Capacity: Normative Data for Six Standardized Motor Tasks
por: Röhling, Hanna Marie, et al.
Publicado: (2022)

Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study
por: Sperber, Pia S., et al.
Publicado: (2022)

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting
por: von Gumberz, Johanna, et al.
Publicado: (2016)

Prognostic Risk Estimates of Patients with Multiple Sclerosis and Their Physicians: Comparison to an Online Analytical Risk Counseling Tool
por: Heesen, Christoph, et al.
Publicado: (2013)

Magnetic Resonance Imaging in Multiple Sclerosis – Patients' Experiences, Information Interests and Responses to an Education Programme
por: Brand, Judith, et al.
Publicado: (2014)

MRI Pattern Recognition in Multiple Sclerosis Normal-Appearing Brain Areas
por: Weygandt, Martin, et al.
Publicado: (2011)

T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients
por: Thaler, Christian, et al.
Publicado: (2015)

Feasibility of a smartphone app to enhance physical activity in progressive MS: a pilot randomized controlled pilot trial over three months
por: Nasseri, Navina N., et al.
Publicado: (2020)

Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosis
por: Stellmann, Jan-Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bicb2g3f2nkdu6foqesllutnhi